IFP Advisors, Inc - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 193 filers reported holding IMMUNOGEN INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$5,094
+139.4%
321
+129.3%
0.00%
Q2 2023$2,128
+163.7%
140
+100.0%
0.00%
Q1 2023$807
+80600.0%
700.0%0.00%
Q4 2022$1
-99.9%
700.0%0.00%
Q3 2022$1,0000.0%700.0%0.00%
Q2 2022$1,000
-50.0%
70
-50.0%
0.00%
Q1 2022$2,000
+100.0%
140
+100.0%
0.00%
Q4 2021$1,0000.0%700.0%0.00%
Q3 2021$1,000700.0%0.00%
Q2 2021$0
-100.0%
700.0%0.00%
Q1 2021$1,0000.0%70
-69.4%
0.00%
Q4 2020$1,0002290.0%0.00%
Q3 2020$0
-100.0%
2290.0%0.00%
Q2 2020$1,0002290.0%0.00%
Q1 2020$0
-100.0%
229
+44.0%
0.00%
Q4 2019$1,000159
-25.7%
0.00%
Q3 2019$0
-100.0%
214
-89.3%
0.00%
-100.0%
Q1 2019$5,000
-73.7%
2,000
-53.0%
0.00%0.0%
Q4 2018$19,000
-53.7%
4,259
-2.3%
0.00%
-50.0%
Q3 2018$41,000
-4.7%
4,358
-2.3%
0.00%0.0%
Q2 2018$43,000
+48.3%
4,459
-1.6%
0.00%
+100.0%
Q1 2018$29,0000.0%4,5310.0%0.00%0.0%
Q4 2017$29,000
-14.7%
4,531
+0.6%
0.00%0.0%
Q3 2017$34,000
-15.0%
4,503
-19.5%
0.00%
-50.0%
Q2 2017$40,000
+81.8%
5,596
-3.5%
0.00%
+100.0%
Q1 2017$22,000
+633.3%
5,796
+252.6%
0.00%
Q4 2016$3,0000.0%1,644
+39.1%
0.00%
Q3 2016$3,000
-25.0%
1,182
-9.7%
0.00%
Q2 2016$4,000
-20.0%
1,309
-34.6%
0.00%
-100.0%
Q1 2016$5,000
-68.8%
2,000
+65.4%
0.00%0.0%
Q4 2015$16,0001,2090.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 10,477,879$37,720,0000.69%
QVT Financial LP 1,375,900$4,953,0000.60%
RA Capital Management 7,040,485$25,346,0000.46%
Birchview Capital, LP 380,000$1,368,0000.46%
XTX MARKETS LLC 18,861$68,0000.33%
Fernwood Investment Management, LLC 154,340$556,0000.26%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$375,0000.14%
Virtus ETF Advisers LLC 70,213$253,0000.13%
KENNEDY CAPITAL MANAGEMENT LLC 1,251,458$4,505,0000.13%
Assenagon Asset Management S.A. 4,987,334$17,954,0000.10%
View complete list of IMMUNOGEN INC shareholders